India Cipla slashes generic price of Bayer's Nexavar
Quote:
In March, India stripped Bayer of its exclusive rights to sell Nexavar, a treatment for kidney and liver cancer, granting Natco Pharma a license to sell the generic drug at 8,880 rupees ($170) for a monthly dose. Bayer sells the branded Nexavar at 284,428 rupees a month.
That decision was seen as setting a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms.
Thought this was a nice story. Life held above profits for once.
_________________
*some atheist walks outside and picks up stick*
some atheist to stick: "You're like me!"
08 May 2012, 10:30 am
